Get notified when COAG files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: COAG Hemab Therapeutics Holdings, Inc. 8-K

Hemab Therapeutics reports Q1 2026 financial results

Filed May 21, 2026 · Period ending May 21, 2026 · ~1 min read

Key Changes

  • medium

    Company announced financial results for the quarter ended March 31, 2026 via press release. Specific financial metrics not disclosed in the 8-K filing itself.

    Item 2.02 verify on EDGAR →
  • low

    This is a routine quarterly earnings disclosure. Detailed financial data is contained in the attached press release (Exhibit 99.1).

    8-K: Earnings verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.

Partner

Trade COAG commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov

Source-verified from EDGAR · Narrative written by AI · May 24, 2026 · How we verify